🇺🇸 GSK plcGLAXF
Get GSK plc filings on Telegram the moment they are published.
Follow GSK plc on TelegramOne tap starts your 30-day free trial. No card needed.
Subject: 6-K — Foreign issuer report
Overview: The FDA granted accelerated approval to Nelkarmi (neladalkib) for adults with previously-treated advanced ALK-positive non-small cell lung cancer.
Source: SEC EDGAR · Original filing
Get filings like this in Telegram the moment they are published — for the companies you follow.
Start 30-day trial About Finterest